SCHEMBL7225827

SCHEMBL7225827

C/C(=N\O)N(O)CCCC[C@H](N)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 8/20 0.49
NOS1 P29475 6/20 0.49
NOS3 P29474 4/20 0.49
CYP1A2 P05177 2/20 0.49
TSHR P16473 2/20 0.49
CYP3A4 P08684 1/20 0.49
BLM P54132 1/20 0.47
CYP2C19 P33261 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
GSR P00390 1/20 0.46
ARG2 P78540 4/20 0.42
ARG1 P05089 3/20 0.42
GLA P06280 1/20 0.41
NFKB1 P19838 1/20 0.41
APEX1 P27695 1/20 0.41
DDAH1 O94760 2/20 0.41
THPO P40225 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7225831 1.00 NOS2 (0.49) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL1331744 0.83 GSR (0.52) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL1331746 0.83 GSR (0.52) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7220293 0.80 NOS2 (0.54) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7901280 0.80 NOS2 (0.46) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7901279 0.80 NOS2 (0.46) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7909642 0.79 NOS2 (0.43) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7909648 0.79 NOS2 (0.43) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7219068 0.78 NOS2 (0.43) NOS2NOS1NOS3CYP1A2TSHR
SCHEMBL7219063 0.78 NOS2 (0.43) NOS2NOS1NOS3CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US claimed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP claimed
WO-1997032844-A9 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS 1997-12-24 WO claimed
US-6576780-B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors GD SEARLE & COMPANY 2003-06-10 US disclosed